1. All Products
  2. DILTIAZEM hydrochloride, 25mg, powder, vial
Public Pricelist

DILTIAZEM hydrochloride, 25mg, powder, vial

https://unicat.msf.org/cat/product/53862
STD DINJDILT2V-

Valid Article

Former Code(s): -X DINJZFR0195 DINJZBE0041
The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
12.1 - Antianginal medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
12.2 - Antiarrhythmic medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
12.3 - Antihypertensive medicines
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
C08DB01
Anatomical Therapeutic Chemical Classification according to WHOCC
S
The order of this product needs to be justified and is only acceptable under certain conditions.
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
https://unicat.msf.org/web/image/product.template/569594/image_1920?unique=b11bd57

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

DILTIAZEM hydrochloride

Therapeutic Action

Calcium-channel blocker, antiarrhythmic

Indications

Rapid conversion to a normal sinus rhythm of paroxysmal supraventricular
tachycardias (SVT)

Verapamil is preferred for the same indication

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Reconstitute the powder vial with water for injection.

Must be given as direct IV injection or IV infusion in 5% dextrose or 0.9% NaCl.

Administer only in hospital settings with monitoring and cardiorespiratory resuscitation equipment available for immediate use.

During administration, continuous ECG monitoring is necessary due to the risk of fatal arrhythmias.

Verapamil or adenosine may be used as alternative in case of supply constraints.

Contact your OC anaesthetist advisor for more details on posology.

Precautions for Use

Do not administer in children.

  • Contraindicated in severe hypotension, heart failure with reduced ejection fraction, and WPW syndrome with atrial fibrillation.
  • Do not combine with beta‑blockers due to risk of severe bradycardia or heart block.

Storage

  • Below 25ºC
  • After opening/reconstitution/dilution, use the product immediately.